Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study.
Pezzolo E, Rossi M, Caroppo F, Bianchelli T, Belloni Fortina A, Giacchetti A, Calzavara Pinton P, Naldi L. Pezzolo E, et al. Among authors: giacchetti a. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):e757-e759. doi: 10.1111/jdv.18889. Epub 2023 Feb 6. J Eur Acad Dermatol Venereol. 2023. PMID: 36662631 No abstract available.
Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.
Pezzolo E, Gambardella A, Guanti M, Bianchelli T, Bertoldi A, Giacchetti A, Donini M, Argenziano G, Naldi L. Pezzolo E, et al. Among authors: giacchetti a. J Am Acad Dermatol. 2023 Aug;89(2):430-432. doi: 10.1016/j.jaad.2023.04.056. Epub 2023 May 5. J Am Acad Dermatol. 2023. PMID: 37150301 No abstract available.
Controls on spatial variation in porewater methane concentrations across United States tidal wetlands.
Koontz EL, Parker SM, Stearns AE, Roberts BJ, Young CM, Windham-Myers L, Oikawa PY, Megonigal JP, Noyce GL, Buskey EJ, Derby RK, Dunn RP, Ferner MC, Krask JL, Marconi CM, Savage KB, Shahan J, Spivak AC, St Laurent KA, Argueta JM, Baird SJ, Beheshti KM, Crane LC, Cressman KA, Crooks JA, Fernald SH, Garwood JA, Goldstein JS, Grothues TM, Habeck A, Lerberg SB, Lucas SB, Marcum P, Peter CR, Phipps SW, Raposa KB, Rovai AS, Schooler SS, Twilley RR, Tyrrell MC, Uyeda KA, Wulfing SH, Aman JT, Giacchetti A, Cross-Johnson SN, Holmquist JR. Koontz EL, et al. Among authors: giacchetti a. Sci Total Environ. 2024 Dec 20;957:177290. doi: 10.1016/j.scitotenv.2024.177290. Epub 2024 Nov 16. Sci Total Environ. 2024. PMID: 39491559 Free article.
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis.
Prignano F, Argenziano G, Bardazzi F, Borroni RG, Brunasso AMG, Burlando M, Cagni AE, Campione E, Cinotti E, Colonna F, Cuccia A, Dastoli S, De Pasquale R, De Simone C, Di Lernia V, Dini V, Fabbrocini G, Galluzzi C, Giacchetti A, Giofrè C, Lasagni C, Lembo S, Loconsole F, Montesu MA, Pella P, Piaserico S, Pigatto P, Richetta AG, Scuotto A, Stroppiana E, Venturini M, Vinci AS, Zichichi L, Fargnoli MC. Prignano F, et al. Among authors: giacchetti a. J Clin Med. 2023 Dec 24;13(1):101. doi: 10.3390/jcm13010101. J Clin Med. 2023. PMID: 38202108 Free PMC article.
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis.
Stingeni L, Bianchi L, Antonelli E, Caroppo ES, Ferrucci SM, Gurioli C, Ortoncelli M, Fabbrocini G, Nettis E, Schena D, Napolitano M, Gola M, Bonzano L, Rossi M, Belloni Fortina A, Balato A, Peris K, Foti C, Guarneri F, Romanelli M, Patruno C, Savoia P, Esposito M, Russo F, Errichetti E, Bianchelli T, Bianchi L, Pellacani G, Feliciani C, Offidani A, Corazza M, Micali G, Milanesi N, Malara G, Chiricozzi A, Tramontana M, Hansel K; DADA - Dupilumab for Atopic Dermatitis of the Adolescence study group. Stingeni L, et al. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e384-e388. doi: 10.1111/jdv.18648. Epub 2022 Oct 18. J Eur Acad Dermatol Venereol. 2023. PMID: 36225088 No abstract available.
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints.
Rupoli S, Goteri G, Morsia E, Torre E, Giantomassi F, Campanati A, Offidani AM, Molinelli E, Brandozzi G, Serresi S, Giacchetti A, Bugatti L, Filosa G, Mozzicafreddo G, Simonacci M, Olivieri A. Rupoli S, et al. Among authors: giacchetti a. Dermatol Ther. 2022 Oct;35(10):e15737. doi: 10.1111/dth.15737. Epub 2022 Aug 9. Dermatol Ther. 2022. PMID: 35903895
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing.
Prignano F, Brunasso AMG, Fabbrocini G, Argenziano G, Bardazzi F, Borroni RG, Burlando M, Cagni AE, Campione E, Cinotti E, Cuccia A, Dastoli S, De Pasquale R, De Simone C, Di Lernia V, Dini V, Fargnoli MC, Faure E, Giacchetti A, Giofrè C, Girolomoni G, Lasagni C, Lembo S, Loconsole F, Montesu MA, Pella P, Pigatto P, Richetta AG, Stroppiana E, Venturini M, Zichichi L, Piaserico S. Prignano F, et al. Among authors: giacchetti a. J Clin Med. 2022 May 16;11(10):2801. doi: 10.3390/jcm11102801. J Clin Med. 2022. PMID: 35628929 Free PMC article.
35 results